The Democratization of Data Science Education
The future of data science education in a data democratized world.
The future of data science education in a data democratized world.
It might just reinvent the entire medical publishing process.
For outstanding advocacy, innovation or contribution to scholarly peer review.
Bo Rothstein quits Blavatnik School of Government post after learning that patron is a major financial backer of US president.
A few examples that demonstrate how universities design their open science guides.
Data labs, and the scant motivations for sharing data in basic science.
Why the view that women are gentle, caring and empathetic, whereas men are strong, rational and dominant, is misguided.
With help from drug companies, Omics International is making millions as it roils the scientific community with sketchy publications.
Old fights about radio have lessons for new fights about the Internet.
This week, six communities launched preprint services to accelerate dissemination of research.
How cryptocurrencies may generate capital for scientific funding via dividend reinvestment.
Whatever the future may hold, hyperloops, Mars or otherwise, it is the culture of research that will support our world-class researchers to deliver at their best.
When you think of innovation, you also may think of patents and profits. But two Swiss researchers argue that we should be focusing more on people and places.
Ultimately, a key question is emerging for higher education institutions: to what extent, and under what conditions, does it make sense to outsource core scholarly infrastructure?
After a post-election frenzy to save government data, open-access advocates are refocusing their energies toward a long-term strategy.
Energy researcher Daniel Kammen faults US president’s positions on climate change and energy and his failure to condemn white supremacists.
A template for responding the invitations for editorial and reviewer tasks for journals that you wish to boycott.
It took a polymath to pin down the true nature of ‘information’. His answer was both a revelation and a return.
New restrictions hamper access to websites useful for research.
Approval of Novartis cancer drug is “historic,” FDA says
Wise and honourable assessors of grant applications must be allowed to use their discretion, says Sui Huang